|
Thursday 25th May 2017 |
Text too small? |
SeaDragon, which manufactures fish oils for health supplements, confirmed its 2017 annual loss would widen, in line with its previous guidance.
The Nelson-based fish oil refiner said its management and auditors are currently working through the year-end audit process, and it expects to report a loss of $4.3 million to $4.5 million on a normalised earnings before interest, tax, depreciation and amortisation basis, versus a 2016 loss of $400,000. That's in line with its previous guidance released March 1.
The earnings for the year ended March 31 will be released on of before May 31, the company said.
SeaDragon has previously attributed the loss to the length of time it has taken to transition from its legacy Omega-2 business to Omega-3 fish oil produced by its new refinery.
The shares were unchanged at 0.6 cents and have fallen 50 percent over the past year.
(BusinessDesk)
No comments yet
PYS - PaySauce to announce F26 full year results on 27 May 2026
PEB - Draft LCD Proposes Medicare Coverage for Triage and Triage
MEL - Meridian Energy monthly operating report for April 2026
FBU - Sale of South Australian property
AIR - Air New Zealand market update
May 14th Morning Report
PEB - Pacific Edge Placement Increased to NZ$25.4 Million
Radius Care Reports Earnings Growth and 50% Higher Dividend
May 13th Morning Report
Pacific Edge launches capital raise of NZ$24 million